Cargando…
Translational Pharmacokinetic/Pharmacodynamic Model for mRNA-3927, an Investigational Therapeutic for the Treatment of Propionic Acidemia
Propionic acidemia (PA) is an ultrarare disorder caused by deficiency of the mitochondrial enzyme, propionyl-CoA carboxylase (PCC), composed of PCCA and PCCB subunits. An enzyme replacement therapy is being developed using dual messenger RNA (mRNA) therapy composed of lipid nanoparticles (LNPs) enca...
Autores principales: | Attarwala, Husain, Lumley, Matthew, Liang, Min, Ivaturi, Vijay, Senn, Joe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066765/ https://www.ncbi.nlm.nih.gov/pubmed/36577040 http://dx.doi.org/10.1089/nat.2022.0036 |
Ejemplares similares
-
Secondary Hemophagocytosis in Propionic Acidemia
por: Kasapkara, Cigdem Seher, et al.
Publicado: (2015) -
Prevalence of propionic acidemia in China
por: Zhang, Yixing, et al.
Publicado: (2023) -
Unique neuroradiological findings in propionic acidemia
por: Pfeifer, Cory M., et al.
Publicado: (2018) -
Chronic Kidney Disease in Propionic Acidemia
por: Shchelochkov, Oleg A., et al.
Publicado: (2019) -
Anaesthetic considerations for liver transplantation in propionic acidemia
por: Rajakumar, Akila, et al.
Publicado: (2016)